LOREEV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loreev, and what generic alternatives are available?
Loreev is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in LOREEV is lorazepam. There are eleven drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loreev
A generic version of LOREEV was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LOREEV?
- What are the global sales for LOREEV?
- What is Average Wholesale Price for LOREEV?
Summary for LOREEV
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for LOREEV |
| DailyMed Link: | LOREEV at DailyMed |
US Patents and Regulatory Information for LOREEV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-001 | Aug 27, 2021 | RX | Yes | No | 8,999,393 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-003 | Aug 27, 2021 | RX | Yes | Yes | 8,999,393 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-004 | Feb 16, 2022 | RX | Yes | No | 8,999,393 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-002 | Aug 27, 2021 | RX | Yes | No | 8,999,393 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
